3rd Quarter - Report — THE MICHAEL J. FOX FOUNDATION FOR PARKI… for THE MICHAEL J. FOX FOUNDATION FOR PARKI… (2021)

Firm

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH

Client

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH

Income

—

Expenses

$52,751

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

General education regarding the importance of the Department of Defense medical research programs for military service personnel and Veterans living with Parkinson's disease. Inclusion of Parkinson's disease and PD-related diseases as presumptive conditions when military Veterans are exposed to associated toxins

Lobbyist	Covered position, as disclosed
AARON POLACEK	Associate Director, Public Policy
DUSTIN WATSON	Director of Government Relations

Contacted: Environmental Protection Agency (EPA); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Expanding Medicare benefits to include dental, hearing, and vision Telehealth flexibilities and making current telehealth rules permanent Medicare Part D design and benefits, drug pricing principle S.464/H.R.2163, the Safe Step Act of 2021 S.8282/H.R.432, the Mental Health Access Improvement Act H.R.2080, the Seniors Access to Vaccine Ensured Act H.R.3173, Improving Seniors Timely Access to Care S.2061, the Telemental Health Care Access Act

Lobbyist	Covered position, as disclosed
AARON POLACEK	Associate Director, Public Policy
DUSTIN WATSON	Director of Government Relations

Contacted: Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); SENATE; Food & Drug Administration (FDA)

Bills named: S. 464 (117th), H.R. 2080 (117th), H.R. 2163 (117th), S. 8282 (117th), H.R. 3173 (117th), S. 2061 (117th), H.R. 432 (117th)

Pharmacy PHA

General education around pharmaceuticals related to Parkinson's disease

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy
DUSTIN WATSON	Director of Government Relations

Contacted: Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Agriculture AGR

General education on triggers of Parkinson's disease, including TCE, paraquat, and other chemicals.

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy
DUSTIN WATSON	Director of Government Relations

Contacted: Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Environment/Superfund ENV

General education regarding environmental triggers of neurological disease and support for more research.

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy
DUSTIN WATSON	Director of Government Relations

Contacted: Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Budget/Appropriations BUD

FY 2022 Appropriation bills including funding requests for: Department of Defense National Institute of Health Centers for Disease Control and Prevention Food and Drug Administration

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy
DUSTIN WATSON	Director of Government Relations

Contacted: Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Health Issues HCR

General Parkinson's disease information about symptoms, triggers, health coverage, health costs, social determinants of health related to Parkinson's disease and data collection, research, and health access for underserved communities Advocating for Parkinson's patients during COVID-19 including extension of health care subsidies S.253 the Cannabidiol and Marihuana Research Expansion Act S.1467/H.R.2916 the VA Medicinal Cannabis Research Act S.1670/H.R.3321 the Credit for Caring Act S.464/H.R.2163 Safe Step Act H.R.3013 COVID Vaccine Transportation Access Act H.R.2503 Social Determinants Accelerator Act of 2021

Lobbyist	Covered position, as disclosed
AARON POLACEK	Associate Director, Public Policy

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: S. 1467 (117th), S. 464 (117th), H.R. 2916 (117th), S. 1670 (117th), H.R. 3321 (117th), H.R. 3013 (117th), S. 253 (117th), H.R. 2503 (117th), H.R. 2163 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.